We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+13.69%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$222M |
| 2 |
Palantir
PLTR
|
+$221M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$213M |
| 4 |
FirstEnergy
FE
|
+$189M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$383M |
| 2 |
Philip Morris
PM
|
+$280M |
| 3 |
Entergy
ETR
|
+$207M |
| 4 |
Paychex
PAYX
|
+$206M |
| 5 |
Gilead Sciences
GILD
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.81% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 9.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
MGIC Investment
MTG
$6.37B
| $757K | ﹤0.01% |
27,175
+3,649
| +16% | +$93.9K |
|
1227
NETGEAR
NTGR
$578M
| $755K | ﹤0.01% |
25,957
-44,856
| -63% | -$1.2M |
|
1228
Tennant Co
TNC
$1.19B
| $754K | ﹤0.01% |
9,730
-2,171
| -18% | -$160K |
|
1229
Autoliv
ALV
$8.95B
| $743K | ﹤0.01% |
6,639
-131
| -2% | -$12.8K |
|
1230
RingCentral
RNG
$5.79B
| $739K | ﹤0.01% |
26,054
-579
| -2% | -$14.9K |
|
1231
Cognizant
CTSH
$28.9B
| $738K | ﹤0.01% |
9,453
+7,279
| +335% | +$558K |
|
1232
Boeing
BA
$166B
| $731K | ﹤0.01% |
3,488
-36,585
| -91% | -$6.91M |
|
1233
Worthington Enterprises
WOR
$2.81B
| $726K | ﹤0.01% |
11,414
+17
| +0.1% | +$942 |
|
1234
Globus Medical
GMED
$11.2B
| $724K | ﹤0.01% |
12,267
-361
| -3% | -$23.3K |
|
1235
Middleby
MIDD
$5.11B
| $719K | ﹤0.01% |
4,995
-101
| -2% | -$14.2K |
|
|
JBS
1236
JBS N.V.
JBS
$44.7B
| $713K | ﹤0.01% |
+48,827
| New | +$687K |
|
1237
Louisiana-Pacific
LPX
$5B
| $710K | ﹤0.01% |
8,252
-88
| -1% | -$7.82K |
|
1238
Crocs
CROX
$5.88B
| $708K | ﹤0.01% |
6,994
-30
| -0.4% | -$3.06K |
|
|
MASI
1239
DELISTED
Masimo
MASI
| $707K | ﹤0.01% |
4,201
-46,801
| -92% | -$7.47M |
|
1240
Commerce Bancshares
CBSH
$8.32B
| $705K | ﹤0.01% |
11,902
-236
| -2% | -$13.8K |
|
1241
Xometry
XMTR
$5.41B
| $699K | ﹤0.01% |
20,673
-16,598
| -45% | -$487K |
|
1242
Digital Realty Trust
DLR
$68.8B
| $696K | ﹤0.01% |
3,995
-13
| -0.3% | -$2.13K |
|
1243
Puma Biotechnology
PBYI
$469M
| $694K | ﹤0.01% |
202,335
+1,373
| +0.7% | +$4.38K |
|
|
SNV
1244
DELISTED
Synovus
SNV
| $689K | ﹤0.01% |
13,313
-390
| -3% | -$17.9K |
|
1245
Consolidated Edison
ED
$39.7B
| $688K | ﹤0.01% |
6,852
-3,067
| -31% | -$325K |
|
1246
Toro Company
TTC
$9.43B
| $687K | ﹤0.01% |
9,717
+189
| +2% | +$13.4K |
|
1247
SOPHiA GENETICS
SOPH
$698M
| $682K | ﹤0.01% |
220,000
+31,000
| +16% | +$92.4K |
|
1248
Prestige Consumer Healthcare
PBH
$2.47B
| $681K | ﹤0.01% |
8,530
-660
| -7% | -$55.2K |
|
1249
Churchill Downs
CHDN
$6.28B
| $681K | ﹤0.01% |
6,743
-217
| -3% | -$21.2K |
|
1250
Privia Health
PRVA
$2.65B
| $675K | ﹤0.01% |
29,352
-376
| -1% | -$8.71K |
|
Similar funds
Federated Hermes's Q2 2025 Portfolio in Review
As of Q2 2025, Federated Hermes held 2,220 positions worth $53.1B, up 15% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.33B of net new capital in Q2 2025, opening 169 new positions and adding to 729 existing holdings. Its largest new stake was Genuine Parts: 882,160 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $383M trimmed.
- Federated Hermes's largest Q2 2025 buy was Genuine Parts: 882,160 shares worth $107M.
- Federated Hermes added most to Zscaler in Q2 2025, an estimated $222M increase.
- Federated Hermes's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $383M.
- Federated Hermes fully exited Regulus Therapeutics in Q2 2025, selling an estimated $39.2M.
- Federated Hermes's ten largest holdings make up 15% of its $53.1B portfolio in Q2 2025.
- Federated Hermes opened 169 new positions and closed 165 in Q2 2025.
- Federated Hermes's portfolio value rose 15% quarter-over-quarter to $53.1B.
Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.